1887

Abstract

Bacterial efflux pumps exhibit functional interplay that can translate to additive or multiplicative effects on resistance to antimicrobial compounds. In diderm bacteria, two different efflux pump structural types – single-component inner membrane efflux pumps and cell envelope-spanning multicomponent systems – cooperatively export antimicrobials with cytoplasmic targets from the cell. Harnessing our recently developed efflux platform, which is built upon an extensively efflux-deficient strain of , here we explore interplay amongst a panel of diverse efflux pumps. Specifically, we assessed the effect of simultaneously expressing two efflux pump-encoding genes on drug resistance, including single-component inner membrane efflux pumps (MdfA, MdtK and EmrE), tripartite complexes (AcrAB, AcrAD, MdtEF and AcrEF), and the acquired TetA(C) tetracycline resistance pump. Overall, the expression of two efflux pump-encoding genes from the same structural type did not enhance resistance levels regardless of the antimicrobial compound or efflux pump under investigation. In contrast, a combination of the tripartite efflux systems with single-component pumps sharing common substrates provided multiplicative increases to antimicrobial resistance levels. In some instances, resistance was increased beyond the product of resistance provided by the two pumps individually. In summary, the developed efflux platform enables the isolation of efflux pump function, facilitating the identification of interactions between efflux pumps.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.001261
2022-11-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/micro/168/11/mic001261.html?itemId=/content/journal/micro/10.1099/mic.0.001261&mimeType=html&fmt=ahah

References

  1. Zgurskaya HI, Rybenkov VV. Permeability barriers of gram-negative pathogens. Ann N Y Acad Sci 2020; 1459:5–18 [View Article]
    [Google Scholar]
  2. Silver LL. A gestalt approach to gram-negative entry. Bioorg Med Chem 2016; 24:6379–6389 [View Article]
    [Google Scholar]
  3. Delcour AH. Outer membrane permeability and antibiotic resistance. Biochim Biophys Acta 2009; 1794:808–816 [View Article] [PubMed]
    [Google Scholar]
  4. Teelucksingh T, Thompson LK, Cox G. The evolutionary conservation of Escherichia coli drug efflux pumps supports physiological functions. J Bacteriol 2020; 202:e00367-20 [View Article]
    [Google Scholar]
  5. Piddock LJV. Multidrug-resistance efflux pumps - not just for resistance. Nat Rev Microbiol 2006; 4:629–636 [View Article]
    [Google Scholar]
  6. Cox G, Wright GD. Intrinsic antibiotic resistance: mechanisms, origins, challenges and solutions. Int J Med Microbiol 2013; 303:287–292 [View Article] [PubMed]
    [Google Scholar]
  7. Lee A, Mao W, Warren MS, Mistry A, Hoshino K et al. Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance. J Bacteriol 2000; 182:3142–3150 [View Article] [PubMed]
    [Google Scholar]
  8. Nishino K, Yamaguchi A. Analysis of a complete library of putative drug transporter genes in Escherichia coli. . J Bacteriol 2001; 183:5803–5812 [View Article] [PubMed]
    [Google Scholar]
  9. Saier MH. A functional-phylogenetic classification system for transmembrane solute transporters. Microbiol Mol Biol Rev 2000; 64:354–411 [View Article]
    [Google Scholar]
  10. Delmar JA, Yu EW. The AbgT family: a novel class of antimetabolite transporters. Protein Science 2016; 25:322–337 [View Article]
    [Google Scholar]
  11. Hassan KA, Liu Q, Elbourne LDH, Ahmad I, Sharples D et al. Pacing across the membrane: the novel PACE family of efflux pumps is widespread in Gram-negative pathogens. Res Microbiol 2018; 169:450–454 [View Article] [PubMed]
    [Google Scholar]
  12. Teelucksingh T, Thompson LK, Zhu S, Kuehfuss NM, Goetz JA et al. A genetic platform to investigate the functions of bacterial drug efflux pumps. Nat Chem Biol 2022; 2022:1–11 [View Article]
    [Google Scholar]
  13. Krishnamoorthy G, Wolloscheck D, Weeks JW, Croft C, Rybenkov VV et al. Breaking the permeability barrier of Escherichia coli by controlled hyperporination of the outer membrane. Antimicrob Agents Chemother 2016; 60:7372–7381 [View Article]
    [Google Scholar]
  14. Saier MH Jr, Paulsen IT. Phylogeny of multidrug transporters. Semin Cell Dev Biol 2001; 12:205–213 [View Article]
    [Google Scholar]
  15. Zgurskaya HI, Malloci G, Chandar B, Vargiu AV, Ruggerone P. Bacterial efflux transporters’ polyspecificity - a gift and a curse?. Current Opinion in Microbiology 2021; 61:115–123 [View Article]
    [Google Scholar]
  16. Kobylka J, Kuth MS, Müller RT, Geertsma ER, Pos KM. AcrB: a mean, keen, drug efflux machine. Ann N Y Acad Sci 2020; 1459:38–68 [View Article] [PubMed]
    [Google Scholar]
  17. Tal N, Schuldiner S. A coordinated network of transporters with overlapping specificities provides a robust survival strategy. Proc Natl Acad Sci U S A 2009; 106:9051–9056 [View Article]
    [Google Scholar]
  18. Johnson JW, Ellis MJ, Piquette ZA, MacNair C, Carfrae L et al. Antibacterial activity of metergoline analogues: revisiting the Ergot Alkaloid Scaffold for antibiotic discovery. ACS Med Chem Lett 2022; 13:284–291 [View Article]
    [Google Scholar]
  19. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 2000; 97:6640–6645 [View Article] [PubMed]
    [Google Scholar]
  20. Cox G, Sieron A, King AM, De Pascale G, Pawlowski AC et al. A common platform for antibiotic dereplication and adjuvant discovery. Cell Chem Biol 2017; 24:98–109 [View Article]
    [Google Scholar]
  21. Cherepanov PP, Wackernagel W. Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 1995; 158:9–14 [View Article] [PubMed]
    [Google Scholar]
  22. Sutcliffe JG. Complete nucleotide sequence of the Escherichia coli plasmid pBR322. Cold Spring Harb Symp Quant Biol 1979; 43:77–90 [View Article]
    [Google Scholar]
  23. McNicholas P, Chopra I, Rothstein DM. Genetic analysis of the tetA(C) gene on plasmid pBR322. J Bacteriol 1992; 174:7926–7933 [View Article] [PubMed]
    [Google Scholar]
  24. Patel JB, Cockerill RF, Bradford AP, Eliopoulos MG, Hindler AJ et al. M07-A10: methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard. In CLSI (Clinical Lab Stand Institute) 2015 https://clsi.org/media/1632/m07a10_sample.pdf
    [Google Scholar]
  25. Edgar R, Bibi E. MdfA, an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition. J Bacteriol 1997; 179:2274–2280 [View Article] [PubMed]
    [Google Scholar]
  26. Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 2001; 65:232–260 [View Article]
    [Google Scholar]
  27. Gerba CP. Quaternary ammonium biocides: efficacy in application. Appl Environ Microbiol 2015; 81:464–469 [View Article] [PubMed]
    [Google Scholar]
  28. Asadi A, Abdi M, Kouhsari E, Panahi P, Sholeh M et al. Minocycline, focus on mechanisms of resistance, antibacterial activity, and clinical effectiveness: Back to the future. J Glob Antimicrob Resist 2020; 22:161–174 [View Article]
    [Google Scholar]
  29. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Bio 2006; 2:2006.0008 [View Article]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.001261
Loading
/content/journal/micro/10.1099/mic.0.001261
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error